...
首页> 外文期刊>Annals of allergy, asthma, and immunology >Sino-nasal outcome test (SNOT-22): A predictor of postsurgical improvement in patients with chronic sinusitis
【24h】

Sino-nasal outcome test (SNOT-22): A predictor of postsurgical improvement in patients with chronic sinusitis

机译:中鼻综合征试验(Snot-22):慢性鼻窦炎患者的后期改善的预测因子

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background A number of factors are critical when considering the expected benefit of surgical intervention in patients with chronic rhinosinusitis (CRS) who have failed medical therapy. Objective To evaluate the Sino-nasal Outcome Test (SNOT-22) and other patient demographic characteristics as predictors of postsurgical improvement in patients with CRS. Methods Consecutive adult subjects presenting to the Otolaryngology Clinics at the University of Virginia with refractory CRS that required surgery were included. Patients were excluded if they had not completed both preoperative and postoperative SNOT-22 evaluations. Demographic and baseline measures, including asthma and smoking status, total immunuglobulin E (IgE), absolute eosinophil counts, and Lund-Mackay computed tomography (CT) scoring were also obtained for each subject. Regression analyses were performed. Results One hundred four subjects met criteria and were included. These subjects showed a 51% overall improvement in postsurgical SNOT-22 evaluations (95% confidence interval [CI]: [45, 57%], P <.001). Multivariate regression analysis revealed that SNOT-22 items related to "runny nose," "cough," and "sadness" were independent predictors of postsurgical SNOT-22 improvement (P <.05, for all). Although "runny nose" had a direct correlation with improvement, more severe "sadness" and "cough" scores had a negative impact on degree of improvement. Similarly, analyses indicated that questions categorized as pertaining to nasal or ear symptoms were uniquely associated with postsurgical improvement in SNOT-22 scores (P <.001 and P =.015, respectively). Neither Lund-Mackay CT scoring, total IgE, nor absolute eosinophil counts correlated with improvement in postsurgical SNOT-22 scores. Conclusion Physicians can use components of the SNOT-22 to predict likelihood of symptom improvement after surgical intervention in subjects with CRS.
机译:背景技术在考虑医疗治疗失败的慢性鼻窦炎(CRS)患者的外科干预的预期益处时,许多因素是至关重要的。目的评价中鼻果实测试(SNOT-22)和其他患者人口特征作为CRS患者后期改善的预测因子。方法使用难治性CRS在弗吉尼亚大学临床诊断中呈现给耳鼻喉科诊所的连续成人受试者。如果术前和术后鼻涕22评估,患者被排除在外。每个受试者还获得了人口统计和吸烟状态,包括哮喘和吸烟状态,总免疫球蛋白E(IgE),绝对嗜酸性粒细胞计数和Lund-Mackay计算断层扫描(CT)评分。进行回归分析。结果一百四项受试者达到标准。这些受试者显示出51%的后期鼻涕-22评估总体改善(95%置信区间[CI]:[45,57%],P <.001)。多变量回归分析显示,与“流鼻涕”,“咳嗽”和“悲伤”有关的鼻涕22件物品是后勤鼻涕22改善的独立预测因子(P <.05,所有)。虽然“流鼻涕”与改善有直接相关,但更严重的“悲伤”和“咳嗽”得分对改善程度产生负面影响。类似地,分析表明,与鼻腔或耳症状有关的问题,与鼻22分数的后静脉改善(分别为P <.001和P = .015)独特地相关。伦敦麦克风CT批量均不进行,总IgE和绝对嗜酸性粒细胞计数与后勤鼻22分22分的改善相关。结论医生可以使用Snot-22的组件来预测CRS受试者手术干预后症状改善的可能性。

著录项

  • 来源
  • 作者单位

    Asthma and Allergic Disease Center Carter Immunology Center University of Virginia Health System;

    Department of Otolaryngology University of Virginia Health System Charlottesville VA United;

    Department of Otolaryngology University of Pittsburgh Pennsylvania United States;

    Asthma and Allergic Disease Center Carter Immunology Center University of Virginia Health System;

    Asthma and Allergic Disease Center Carter Immunology Center University of Virginia Health System;

    Asthma and Allergic Disease Center Carter Immunology Center University of Virginia Health System;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学免疫学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号